Cardiology

Secondary analysis confirms safety of blood thinning agent

Treatment with the blood thinner apixaban was associated with a lower risk of bleeding, death and hospitalization compared with warfarin, regardless of history of prior stroke or blood clot, according to a secondary analysis ...

Cardiology

Study looks at changes in outcomes for coronary revascularization

The most common type of heart disease—coronary artery disease—affects 6.7% of adults and accounts for 20% of 2 in 10 deaths of adults under age 65. The condition builds over time as inflammation and cholesterol-containing ...

Cardiology

Mayo will test robotic heart procedure for rural patients

Mayo Clinic researchers are poised this spring to test a remote cardiac procedure that could be a major breakthrough for rural hospital care—a procedure in which a patient's clogged artery is propped open by robotic tools ...

Cardiology

Ischemia trial validates current practice standards

The Society for Cardiovascular Angiography & Interventions (SCAI) congratulates the investigators of the ISCHEMIA trial on their very important late-breaking research presented today at the American Heart Association 2019 ...

Cardiology

PCI, CABG for left main CAD have similar five-year outcomes

(HealthDay)—Five-year rates of a composite outcome of death, stroke, and myocardial infarction are similar for patients with left main coronary artery disease following either percutaneous coronary intervention (PCI) or ...

Cardiology

Less bleeding with ticagrelor alone in high-risk patients

(HealthDay)—Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, ...

page 1 from 23